Cargando…

Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers()()

This study evaluates the individual, as well as relative and joint value of indices obtained from magnetic resonance imaging (MRI) patterns of brain atrophy (quantified by the SPARE-AD index), cerebrospinal fluid (CSF) biomarkers, APOE genotype, and cognitive performance (ADAS-Cog) in progression fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Da, Xiao, Toledo, Jon B., Zee, Jarcy, Wolk, David A., Xie, Sharon X., Ou, Yangming, Shacklett, Amanda, Parmpi, Paraskevi, Shaw, Leslie, Trojanowski, John Q., Davatzikos, Christos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871290/ https://www.ncbi.nlm.nih.gov/pubmed/24371799 http://dx.doi.org/10.1016/j.nicl.2013.11.010

Ejemplares similares

Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI
por: Toledo, Jon B., et al.
Publicado: (2013)

An Efficient Combination among sMRI, CSF, Cognitive Score, and APOE ε4 Biomarkers for Classification of AD and MCI Using Extreme Learning Machine
por: Khatri, Uttam, et al.
Publicado: (2020)

Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau
por: Dickerson, Bradford C., et al.
Publicado: (2013)

T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
por: Haris, Mohammad, et al.
Publicado: (2015)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
por: Shen, Li, et al.
Publicado: (2013)

Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease
por: Nho, Kwangsik, et al.
Publicado: (2017)

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition
por: Toledo, Jon B, et al.
Publicado: (2014)

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
por: Galasko, Douglas, et al.
Publicado: (2019)

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
por: Risacher, Shannon L., et al.
Publicado: (2013)

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4
por: Andreasson, U, et al.
Publicado: (2014)

CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders
por: Mattsson, N, et al.
Publicado: (2013)

FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
por: Caminiti, Silvia Paola, et al.
Publicado: (2018)

Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia
por: Oudart, Jean-Baptiste, et al.
Publicado: (2020)

Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population
por: Monge-Argilés, J. A., et al.
Publicado: (2016)

Diurnal oscillation of CSF Aβ and other AD biomarkers
por: Lucey, Brendan P., et al.
Publicado: (2017)

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics
por: Varatharajah, Yogatheesan, et al.
Publicado: (2019)

Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
por: Contador, José, et al.
Publicado: (2021)

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD
por: Fessel, Jeffrey
Publicado: (2020)

CSF Potential Biomarkers Aβ42 and Tau: associations of Apo E Genotype
por: Kandimalla, Ramesh, et al.
Publicado: (2010)

Association of Homocysteine Levels With Medial Temporal Lobe Atrophy Among Carriers and Non-carriers of APOE ε4 in MCI Subjects
por: Ma, Jun, et al.
Publicado: (2022)

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
por: Mollenhauer, Brit, et al.
Publicado: (2017)

CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD
por: Ermann, Natalia, et al.
Publicado: (2018)

Biomarker testing in MCI patients—deciding who to test
por: van Maurik, Ingrid S., et al.
Publicado: (2021)

APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD
por: Manning, Emily N., et al.
Publicado: (2014)

Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial
por: Chen, Guan-Qun, et al.
Publicado: (2016)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
por: Wang, Jun, et al.
Publicado: (2022)

Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection
por: Peterson, Julia, et al.
Publicado: (2014)

Correction: APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD
Publicado: (2014)

Correction: APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD
Publicado: (2014)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
por: Chipi, Elena, et al.
Publicado: (2019)

QEEG- BRAIN MAPPING - A biomarker to predict MCI/ Dementia.
por: Murugappan, SP., et al.
Publicado: (2022)

Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
por: Hong, Shengjun, et al.
Publicado: (2020)

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers
por: Schuff, N., et al.
Publicado: (2009)

Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
por: Bryant, Annie G., et al.
Publicado: (2021)

Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging
por: Ottoy, Julie, et al.
Publicado: (2019)

Alteration of Blood Immune Biomarkers in MCI Patients with Different APOE Genotypes after Cognitive Training: A 1 Year Follow-Up Cohort Study
por: Abramova, Olga, et al.
Publicado: (2023)

Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
por: Toledo, Jon B, et al.
Publicado: (2013)

Chasing the Effects of Pre-Analytical Confounders – A Multicenter Study on CSF-AD Biomarkers
por: Leitão, Maria João, et al.
Publicado: (2015)

Clinical and multimodal biomarker correlates of ADNI neuropathological findings
por: Toledo, Jon B, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6vve3p9ug15pactr7g4qpb73ek